cTnI、NT-proBNP 检测在急性心源性胸痛筛查及预后中的应用  

Application of cTnI and NT-proBNP in screening and prognosis of acute cardiogenic chestpain

作　　者：吴竞 宫立新[1] 黄泽玉 李鹏[1] Wu Jing;Gong Lixin;Huang Zeyu;Li Peng(Emergency Department,Chaohu Hospital Affiliated to Anhui Medical University,Hefei 238000,Anhui)

机构地区：[1]安徽医科大学附属巢湖医院急诊科,安徽合肥238000

出　　处：《现代科学仪器》2024年第5期217-220,共4页Modern Scientific Instruments

摘　　要：目的:分析cTnI、NT-proBNP在急性心源性胸痛(CCP)筛查及预后评估中的应用价值。方法:187例急性胸痛患者,依据病因分为急性CCP组及急性NCCP组,分析CCP发生的危险因素以及血清cTnI、NT-proBNP对CCP预后的评估价值。结果:cTnI、NT-proBNP为急性CCP发生的独立危险因素(P<0.05);死亡组血清cTnI、NT-proBNP水平较存活组高(P<0.05);两者联合检测预测急性CCP预后的效能高于单一指标(P<0.05)。结论:血清cTnI、NT-proBNP是急性CCP发生的危险因素,两者联合检测预测预后的效能更高。Objective:To analyze the application value of cTnI and NT-proBNP in screening and prognosis evaluation of acute CCP.Methods:187 patients with acute chest pain were divided into acute CCP group and acute NCCP group according to the cause.The risk factors for CCP and the evaluation value of serum cTnI and NT-proBNP for the prognosis of CCP were analyzed.Results:cTnI and NT-proBNP were independent risk factors for acute CCP(P<0.05).Serum cTnI and NT-proBNP levels in the death group were higher than those in the survival group(P<0.05).Joint detection of the two was more efficient than each indicatorin predicting the prognosis of acute CCP(P<0.05).Conclusion:Serum cTnI and NT-proBNP are risk factors for acute CCP,and joint detection of the two is more efficient in predicting the prognosis.

关 键 词：急性心源性胸痛 肌钙蛋白I N末端B型脑钠肽 筛查 预后评估 

分 类 号：R459.7[医药卫生—急诊医学]